Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia.
about
Strategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia - a review.The development of targeted new agents to improve the outcome for children with leukemia.Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel.Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia).
P2860
Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Dose-related efficacy and toxi ...... iatric acute myeloid leukemia.
@en
type
label
Dose-related efficacy and toxi ...... iatric acute myeloid leukemia.
@en
prefLabel
Dose-related efficacy and toxi ...... iatric acute myeloid leukemia.
@en
P2093
P2860
P1476
Dose-related efficacy and toxi ...... iatric acute myeloid leukemia.
@en
P2093
D Reinhardt
G J L Kaspers
J Parigger
P2860
P304
P356
10.1586/14737140.2016.1129903
P577
2015-12-08T00:00:00Z